OWLET, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.95 USD | -1.00% |
|
-8.14% | -25.19% |
| May. 06 | Transcript : Owlet, Inc., Q1 2024 Earnings Call, May 06, 2024 | |
| May. 06 | Earnings Flash (OWLT) OWLET Reports Q1 Revenue $14.8M, vs. Street Est of $16.4M | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -25.19% | 35.77M | - | ||
| +12.15% | 228B | B | ||
| +14.90% | 196B | B- | ||
| +18.22% | 141B | B- | ||
| +29.15% | 110B | A- | ||
| +0.53% | 65.88B | A- | ||
| +16.92% | 54.3B | B+ | ||
| +6.33% | 52.39B | B+ | ||
| +10.93% | 45.22B | A | ||
| +5.87% | 37.12B | - |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- OWLT Stock
- Ratings Owlet, Inc.
